AI-Based CBT Enhancement for Mental Health (AFFECT Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It seems focused on therapy sessions rather than medication use.
Research shows that AI-based tools can enhance psychotherapy by providing real-time feedback, improving therapist performance, and increasing patient satisfaction and engagement. Studies have found that AI can help therapists deliver more effective cognitive behavioral therapy (CBT) by offering objective feedback and quality assurance, which can lead to better mental health outcomes.
12345The available research does not specifically address safety concerns for AI-based CBT enhancement tools like LyssnCBT, but these tools are generally used to support therapy by providing feedback and improving therapy quality, which suggests they are safe to use as they do not directly interact with patients in a harmful way.
12367LyssnCBT is unique because it uses artificial intelligence to automatically evaluate the quality of cognitive behavioral therapy (CBT) sessions, providing feedback to therapists to improve their practice. This AI-based approach is scalable, cost-efficient, and helps ensure high-quality therapy by offering real-time recommendations and metrics, which is not typically available in traditional therapy settings.
12346Eligibility Criteria
This trial is for therapists, their supervisors, and clients at Philadelphia community mental health centers. Participants must be able to conduct therapy in English, agree to use session recordings for research, and have internet access.Inclusion Criteria
Participant Groups
- Cognitive Behavioral Therapy (CBT) for mental health disorders and addiction